Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 1 | 7 | 30 | 330 | 9,860 |
| Cost of Goods | 0 | 0 | 0 | 0 | 1,500 |
| Gross Profit | 1 | 7 | 30 | 330 | 8,350 |
| Operating Expenses | 13,040 | 10,470 | 9,300 | 12,620 | 12,360 |
| Operating Income | -13,039 | -10,463 | -9,270 | -12,290 | -3,500 |
| Interest Expense | 0 | 0 | 30 | 50 | 60 |
| Other Income | 1,139 | 443 | 940 | 1,330 | -570 |
| Pre-tax Income | -11,900 | -10,020 | -8,360 | -11,010 | -4,130 |
| Net Income Continuous | -11,909 | -10,024 | -7,940 | -8,800 | -4,138 |
| Net Income | $-11,900 | $-10,020 | $-8,360 | $-11,010 | $-4,130 |
| EPS Basic Total Ops | -146.46 | -146.46 | 151.26 | -211.29 | -88.84 |
| EPS Basic Continuous Ops | -145.41 | -145.28 | -144.63 | -168.91 | -88.04 |
| EPS Diluted Total Ops | -146.46 | -146.46 | 151.26 | -211.29 | -88.84 |
| EPS Diluted Continuous Ops | -145.41 | -145.28 | -144.63 | -168.91 | -88.04 |
| EBITDA(a) | $-12,899 | $-10,343 | $-8,700 | $-12,050 | $-3,190 |